UAE Authority Recalls 3 Food Supplements, 1 Medical Product For Safety Reasons

(MENAFN- Khaleej Times) The EDE confirmed that the products have not been imported with its approval

• PUBLISHED: Wed 25 Feb 2026, 11:46 AM UPDATED: Wed 25 Feb 2026, 1:03 PM

• By:
• Yasmin Hussein

Add as a preferred
source on Google

• Share:

The Emirates Drug Establishment (EDE) has recently issued separate circulars to recall of unauthorized dietary supplements and a medical product from the country's markets.

The circulars, which were shared by EDE on February 20, come as a precautionary measure upon which the EDE initiated the recall of batches and lots of four products to safeguard public health and ensure compliance with regulatory requirements.

Recommended For You

Here are the three food supplements which the EDE ordered their recall:

1. Rosabella Moringa Capsules

The EDE said that it ordered the recalling of specific lots of Rosabella Moringa capsules. It confirmed that it did not authorize this product and that it has not been imported with its permission or approval. However, its sale has been detected through online sales platforms.

Stay up to date with the latest news. Follow KT on WhatsApp Channels.

It further clarified that it has received an important safety update issued by the US Food and Drug Administration (FDA), in coordination with the Centers for Disease Control and Prevention (CDC), regarding the recall of Rosabella Moringa capsules due to contamination with Salmonella bacteria.

The authority affirmed that the its recent circular is a precautionary safety measure that aims at protecting public health. Consumers are advised not to purchase or use this product. All pharmaceutical facilities, other sales outlets are instructed not to sell, store, distribute, purchase, or dispense it.

Specific lots of the product and their expiry dates have been shared for the public to avoid using.

2. Wound Vite

According to a European notification, the EDE said that Wound Vite contains a non-authorised novel food ingredient and is therefore considered non-compliant with relevant regulations. The presence of an unauthorized ingredient raises concerns regarding the product's safety, quality, and regulatory compliance.

At present, this product is not authorized through the official regulatory pathway, and its safety profile has not been evaluated by the competent authority, the EDE said.

The authority urged all stakeholders not to import or procure the product Wound Vite (ZEN NUTRIENTS) through any supply channel, including online platforms. In addition to this, they have to avoid listing or promoting the product on e-commerce platforms, pharmacies, health stores, or any distribution channels within the UAE.

Recommendations also include the following:

• Ensuring that procurement teams and healthcare professionals are informed about regulatory concern and instructed not to purchase or recommend this product.

• Conducting an urgent verification to ensure that the product is not available within healthcare facilities or retail outlets and confirm the absence of any batches of this product.

• Ceasing the distribution, sale, or use of the product.

• Quarantining any available quantities until further instructions are issued by the EDE.

• Immediately reporting to the competent authority any suspected importation, distribution, or use of the product by individuals.

3. Super Immune+

All lots of Super Immune+ are included in another recall circular issued by the EDE which informed the public of a safety alert indicating that the supplement contains a non-authorized novel food ingredient, called dimethylaminoethanol (DMAE), in addition to unauthorized substances such as molybdenum amino acid chelate and boron citrate in food supplements.

The UAE authority clarified that it did not authorize this product and that Super immune+ has not been imported with its permission or approval; however, its sale has been detected through online sales websites.

Consumers are warned against buying or using the product and all online platforms must refrain from selling or listing the product in the country.

Another product recall

Some batches of Isotonac-4 (MEK-641D) were also recalled due to a quality defect. The defect was identified following a background testing that detected whitish particles and abnormal platelet (PLT) findings, indicating that the affected batches may not meet the required quality and performance standards in the UAE.

The expiry dates of the recalled batches are September-November 2026. The product's manufacturers, marketing authorization holders and distributors are advised to:

• Initiate an immediate market recall

• Immediately stop the distribution, and supply of the affected batches

• Identify, retrieve, and quarantine all affected stock from warehouses, pharmacies, and retail outlets

• Notify all customers and downstream distributors without delay

• Submit a recall status report (quantities, batch numbers, locations, and recall progress)

Healthcare professionals in the UAE should not recommend or dispense the affected batches, advise caregivers to discontinue their use immediately, identify and segregate all available stock and place it under strict quarantine to prevent further distribution. They should also monitor and report any suspected adverse events or product quality complaints to EDE.

ALSO READ

• UAE, Oman recall batch of Aptamil infant formula over bacterial contamination concerns
• UAE recalls more infant formula over safety fears!
• Explained: UAE recalls more infant formula products; 5 questions answered

MENAFN25022026000049011007ID1110786865